MicroPort NeuroScientific Corporation (MicroPort NeuroScientific) has released its 2025 annual general meeting (AGM) circular detailing a cash-and-scrip final dividend, board changes, auditor re-appointment and new share mandates.
Dividend & Scrip Alternative • The Board recommends a final dividend of HK$0.09 per share for FY-2025. • A scrip dividend scheme will allow qualifying shareholders to elect new shares at a 10% discount to the five-day average closing price up to and including the 8 July 2026 record date. • Share register closes 6–8 July 2026; dividend warrants and scrip share certificates are scheduled for dispatch on or about 21 August 2026, with trading expected from 24 August 2026.
Director Elections • Five directors retire and stand for re-election: – Non-executive: Dr. Zhang Jie (Chairman), Mr. Liu Xudong, Ms. Wu Xia – Executive: Mr. Xie Zhiyong (CEO & President) – Independent non-executive: Mr. Liu Thomas A.
Auditor Re-appointment • KPMG (overseas) and KPMG Huazhen LLP (domestic) are proposed for re-appointment for FY-2026, with an estimated audit fee of RMB2.79–2.94 million.
Share Buy-back & Issuance Mandates • Share buy-back mandate: up to 10% of issued shares (excluding treasury shares), equivalent to 57.57 million shares based on the current 575.67 million share base. • Issuance mandate: up to 20% of issued shares (excluding treasury shares), or 115.13 million shares, with an additional extension equal to any shares repurchased. • As of the circular date, the company holds 9.36 million treasury shares; recent on-market repurchases total 0.30 million shares (28–30 April 2026).
AGM Details • Date & time: 10:00 a.m., 3 June 2026 • Venue: 1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Shanghai • Proxy deadline: 10:00 a.m., 1 June 2026 • Voting: all resolutions by poll.
Capital Impact The Board states it has no current plans to fully utilise the mandates and will manage any buy-backs to avoid material adverse effects on working capital or gearing.
Comments